Evaluation of pirfenidone as a new postoperative antiscarring agent in experimental glaucoma surgery

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 6, 2011, Pages 3136-3142

  Zhong, Hua ^a,b   Sun, Guoying ^a   Lin, Xianchai ^a   Wu, Kaili ^a   Yu, Minbin ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MITOMYCIN C; P 2116; PIRFENIDONE; UNCLASSIFIED DRUG; ACTIN; COLLAGEN; CYCLINE; EYE DROPS; MITOMYCIN; NONSTEROID ANTIINFLAMMATORY AGENT; PYRIDONE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTERIOR EYE CHAMBER DEPTH; ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; EXPERIMENTAL MODEL; EYE TOXICITY; FIBROSIS; GLAUCOMA SURGERY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INTRAOCULAR PRESSURE; NONHUMAN; POSTOPERATIVE CARE; PRIORITY JOURNAL; RABBIT; SCAR FORMATION; SLIT LAMP; TOXICITY TESTING; TRABECULECTOMY; ANIMAL; CELL MOTION; CELL PROLIFERATION; CONJUNCTIVA DISEASE; CORNEA ENDOTHELIUM; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; GLAUCOMA; METABOLISM; POSTOPERATIVE COMPLICATION; SCAR; TOPICAL DRUG ADMINISTRATION; ULTRASTRUCTURE;

ACTINS; ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL MOVEMENT; CELL PROLIFERATION; CICATRIX; COLLAGEN; CONJUNCTIVAL DISEASES; DISEASE MODELS, ANIMAL; DRUG EVALUATION; ENDOTHELIUM, CORNEAL; GLAUCOMA; INTRAOCULAR PRESSURE; MITOMYCIN; OPHTHALMIC SOLUTIONS; POSTOPERATIVE COMPLICATIONS; PROLIFERATING CELL NUCLEAR ANTIGEN; PYRIDONES; RABBITS; TRABECULECTOMY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79960931088     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-6240     Document Type: Article

References (27)

1. Khaw PT, Chang L, Wong TT, Mead A, Daniels JT, Cordeiro MF. Modulation of wound healing after glaucoma surgery. Curr Opin Ophthalmol. 2001;12:143-148.
2. Cordeiro MF, Siriwardena D, Chang L, Khaw PT. Wound healing modulation after glaucoma surgery. Curr Opin Ophthalmol. 2000; 11:121-126.
3. Jampel HD, Pasquale LR, Dibernardo C. Hypotony maculopathy following trabeculectomy with mitomycin C. Arch Ophthalmol. 1992;110:1049-1050.
4. Franks WA, Hitchings RA. Complications of 5-fluorouracil after trabeculectomy. Eye. 1991;5:385-389.
5. Higginbotham EJ, Stevens RK, Musch DC, et al. Bleb-related endophthalmitis after trabeculectomy with mitomycin C. Ophthalmology. 1996;103:650-656.
6. Skuta GL, Parrish RK 2nd. Wound healing in glaucoma filtering surgery. Surv Ophthalmol. 1987;32:149-170.
7. Hewitson TD, Kelynack KJ, Tait MG, et al. Pirfenidone reduces in vitro rat renal fibroblast activation and mitogenesis. J Nephrol. 2001;14:453-460.
8. Di Sario A, Bendia E, Svegliati BG, et al. Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production. J Hepatol. 2002;37:584-591.
9. Lee BS, Margolin SB, Nowak RA. Pirfenidone: a novel pharmacological agent that inhibits leiomyoma cell proliferation and collagen production. J Clin Endocrinol Metab. 1998;83:219-223.
10. Iyer SN, Gurujeyalakshmi G, Giri SN. Effects of pirfenidone on transforming growth factor-beta gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis. J Pharmacol Exp Ther. 1999;291:367-373.
11. Gurujeyalakshmi G, Hollinger MA, Giri SN. Pirfenidone inhibits PDGF isoforms in bleomycin hamster model of lung fibrosis at the translational level. Am J Physiol. 1999;276:L311-L318.
12. Oku H, Nakazato H, Horikawa T, Tsuruta Y, Suzuki R. Pirfenidone suppresses tumor necrosis factor-alpha, enhances interleukin-10 and protects mice from endotoxic shock. Eur J Pharmacol. 2002; 446:167-176.
13. Giri SN, Leonard S, Shi X, Margolin SB, Vallyathan V. Effects of pirfenidone on the generation of reactive oxygen species in vitro. J Environ Pathol Toxicol Oncol. 1999;18:169-177.
14. Raghu G, Johnson WC, Lockhart D, Mageto Y. Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective, open-label Phase II study. Am J Respir Crit Care Med. 1999;159:1061-1069.
15. Azuma A, Nukiwa T, Tsuboi E, et al. Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2005;171:1040-1047.
16. Zhang S, Shiels IA, Ambler JS, Taylor SM. Pirfenidone reduces fibronectin synthesis by cultured human retinal pigment epithelial cells. Aust N Z J Ophthalmol. 1998;26(suppl 1):S74-S76.
17. Kim H, Choi YH, Park SJ, et al. Antifibrotic effect of pirfenidone on orbital fibroblasts of patients with thyroid-associated ophthalmopathy by decreasing TIMP-1 and collagen levels. Invest Ophthalmol Vis Sci. 2010;51:3061-3066.
18. Lin X, Yu M, Wu K, Yuan H, Zhong H. Pirfenidone inhibits proliferation, migration, and collagen contraction of human Tenon's fibroblasts in vitro. Invest Ophthalmol Vis Sci. 2009;50:3763-3770.
19. Cordeiro MF, Constable PH, Alexander RA, Bhattacharya SS, Khaw PT. Effect of varying the mitomycin-C treatment area in glaucoma filtration surgery in the rabbit. Invest Ophthalmol Vis Sci. 1997; 38:1639-1646.
20. Wong TT, Mead AL, Khaw PT. Prolonged antiscarring effects of ilomastat and MMC after experimental glaucoma filtration surgery. Invest Ophthalmol Vis Sci. 2005;46:2018-2022.
21. Meyer-Ter-Vehn T, Katzenberger B, Han H, Grehn F, Schlunck G. Lovastatin inhibits TGF-beta-induced myofibroblast transdifferentiation in human tenon fibroblasts. Invest Ophthalmol Vis Sci. 2008;49:3955-3960.
22. Mead AL, Wong TT, Cordeiro MF, Anderson IK, Khaw PT. Evaluation of anti-TGF-beta2 antibody as a new postoperative antiscarring agent in glaucoma surgery. Invest Ophthalmol Vis Sci. 2003;44:3394-3401.
23. Memarzadeh F, Varma R, Lin LT, et al. Postoperative use of bevacizumab as an antifibrotic agent in glaucoma filtration surgery in the rabbit. Invest Ophthalmol Vis Sci. 2009;50:3233-3237.
24. Kalesnykas G, Uusitalo H. Comparison of simultaneous readings of intraocular pressure in rabbits using Perkins handheld, Tono-Pen XL, and TonoVet tonometers. Graefes Arch Clin Exp Ophthalmol. 2007;245:761-762.
25. Miller MH, Grierson I, Unger WI, Hitchings RA. Wound healing in an animal model of glaucoma fistulizing surgery in the rabbit. Ophthalmic Surg. 1989;20:350-357.
26. Gresses MG, Parrish RK II, Folber R. 5-Flurouracil and glaucoma filtering surgery: an animal model. Ophthalmology. 1984;91:378-383.
27. Joseph JP, Miller MH, Hitchings RA. Wound healing as a barrier to successful titration surgery. Eye. 1988;2:S113-S123.